These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33449529)

  • 21. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease.
    Rudilosso S; Chui E; Stringer MS; Thrippleton M; Chappell F; Blair GW; Garcia DJ; Doubal F; Hamilton I; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; van Oostenbrugge R; Duering M; Dichgans M; Wardlaw JM;
    Neurology; 2022 Aug; 99(5):e440-e452. PubMed ID: 35606147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.
    van Rooden S; van den Berg-Huysmans AA; Croll PH; Labadie G; Hayes JM; Viviano R; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2018; 66(3):1283-1294. PubMed ID: 30412485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
    Rudilosso S; Stringer MS; Thrippleton M; Chappell F; Blair GW; Jaime Garcia D; Doubal F; Hamilton I; Janssen E; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; Duering M; Dichgans M; Wardlaw JM;
    J Cereb Blood Flow Metab; 2023 Sep; 43(9):1490-1502. PubMed ID: 37132279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease.
    Lin MP; Brott TG; Liebeskind DS; Meschia JF; Sam K; Gottesman RF
    Stroke; 2020 May; 51(5):1404-1410. PubMed ID: 32248770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-NR2 glutamate receptor antibodies as an early biomarker of cerebral small vessel disease.
    Dobrynina LA; Alexandrova EV; Zabitova MR; Kalashnikova LA; Krotenkova MV; Akhmetzyanov BM
    Clin Biochem; 2021 Oct; 96():26-32. PubMed ID: 34245693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study.
    Camarda C; Torelli P; Pipia C; Battaglini I; Azzarello D; Rosano R; Ventimiglia GD; Sottile G; Cilluffo G; Camarda R
    Curr Alzheimer Res; 2018; 15(11):1013-1026. PubMed ID: 29962342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural network connectivity and cognition in cerebral small vessel disease.
    Tuladhar AM; van Dijk E; Zwiers MP; van Norden AG; de Laat KF; Shumskaya E; Norris DG; de Leeuw FE
    Hum Brain Mapp; 2016 Jan; 37(1):300-10. PubMed ID: 26466741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of white matter lesions and characteristics of small vessel disease markers.
    Park KI; Jung KH; Lee EJ; Lee WJ; Hwang SA; Kim S; Salat DH
    Eur Radiol; 2023 Feb; 33(2):1143-1151. PubMed ID: 35980432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total Small Vessel Disease Score in Neurologically Healthy Japanese Adults in the Kashima Scan Study.
    Yakushiji Y; Charidimou A; Noguchi T; Nishihara M; Eriguchi M; Nanri Y; Kawaguchi A; Hirotsu T; Werring DJ; Hara H
    Intern Med; 2018 Jan; 57(2):189-196. PubMed ID: 29033410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease.
    Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q
    Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of arterial, venous blood and cerebrospinal fluid flow disturbances in forming cognitive impairment types in age-related cerebral microangiophathy].
    Dobrynina LA; Gadzhieva ZS; Akhmetzyanov BM; Kalashnikova LA; Krotenkova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):81-88. PubMed ID: 32207722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
    Pasi M; Boulouis G; Fotiadis P; Auriel E; Charidimou A; Haley K; Ayres A; Schwab KM; Goldstein JN; Rosand J; Viswanathan A; Pantoni L; Greenberg SM; Gurol ME
    Neurology; 2017 Jun; 88(23):2162-2168. PubMed ID: 28476760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total Cerebral Small Vessel Disease MRI Score Is Associated with Cognitive Decline in Executive Function in Patients with Hypertension.
    Uiterwijk R; van Oostenbrugge RJ; Huijts M; De Leeuw PW; Kroon AA; Staals J
    Front Aging Neurosci; 2016; 8():301. PubMed ID: 28018214
    [No Abstract]   [Full Text] [Related]  

  • 35. IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study.
    Staszewski J; Piusińska-Macoch R; Brodacki B; Skrobowska E; Stępień A
    Clin Interv Aging; 2018; 13():1135-1141. PubMed ID: 29950823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognition mediates the relation between structural network efficiency and gait in small vessel disease.
    Cai M; Jacob MA; Norris DG; Duering M; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2021; 30():102667. PubMed ID: 33887698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
    Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
    JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brachial-ankle pulse wave velocity is associated with both acute and chronic cerebral small vessel disease.
    Kim YB; Park KY; Chung PW; Kim JM; Moon HS; Youn YC
    Atherosclerosis; 2016 Feb; 245():54-9. PubMed ID: 26707255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of small vessel disease on motor and cognitive function in Parkinson's disease.
    Shibata K; Sugiura M; Nishimura Y; Sakura H
    Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral and Extracerebral Vasoreactivity in Patients With Different Clinical Manifestations of Cerebral Small-Vessel Disease: Data From the Significance of Hemodynamic and Hemostatic Factors in the Course of Different Manifestations of Cerebral Small-Vessel Disease Study.
    Staszewski J; Skrobowska E; Piusińska-Macoch R; Brodacki B; Stępień A
    J Ultrasound Med; 2019 Apr; 38(4):975-987. PubMed ID: 30208231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.